Scott A. Browne

Array ( [id] => 7149830 [patent_doc_number] => 20040171083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Polymorphisms of the 5\' region of the human 5-HT1A gene, associated proteins of the 5\' region and a diagnostic test for major depression and related mental illnesses' [patent_app_type] => new [patent_app_number] => 10/635855 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6335 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171083.pdf [firstpage_image] =>[orig_patent_app_number] => 10635855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019311 [patent_doc_number] => 20050221330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'GFRalpha3 and its uses' [patent_app_type] => utility [patent_app_number] => 10/621855 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33248 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221330.pdf [firstpage_image] =>[orig_patent_app_number] => 10621855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386719 [patent_doc_number] => 20040029822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Idetification of neural defects associated with the nucleosomal assembly protien 1l 2 gene' [patent_app_type] => new [patent_app_number] => 10/275300 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14118 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029822.pdf [firstpage_image] =>[orig_patent_app_number] => 10275300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363386 [patent_doc_number] => 20040014947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Novel human ependymin-like protein' [patent_app_type] => new [patent_app_number] => 10/612788 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30652 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014947.pdf [firstpage_image] =>[orig_patent_app_number] => 10612788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428166 [patent_doc_number] => 20090087476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'PROSAPOSIN AS A NEUROTROPHIC FACTOR' [patent_app_type] => utility [patent_app_number] => 10/464347 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6330 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087476.pdf [firstpage_image] =>[orig_patent_app_number] => 10464347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4521036 [patent_doc_number] => 07951373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Methods using agonist antibodies to CNS neurite outgrowth modulators' [patent_app_type] => utility [patent_app_number] => 10/457106 [patent_app_country] => US [patent_app_date] => 2003-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 113 [patent_no_of_words] => 48770 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951373.pdf [firstpage_image] =>[orig_patent_app_number] => 10457106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 541760 [patent_doc_number] => 07163701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Controlled release microencapsulated NGF formulation' [patent_app_type] => utility [patent_app_number] => 10/442894 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 17780 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163701.pdf [firstpage_image] =>[orig_patent_app_number] => 10442894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069579 [patent_doc_number] => 20050244964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Production of neural progenitor cells' [patent_app_type] => utility [patent_app_number] => 10/514094 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13082 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244964.pdf [firstpage_image] =>[orig_patent_app_number] => 10514094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083800 [patent_doc_number] => 20050049180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'VGF polypeptides and methods of treating VGF-related disorders' [patent_app_type] => utility [patent_app_number] => 10/424385 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28659 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049180.pdf [firstpage_image] =>[orig_patent_app_number] => 10424385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730079 [patent_doc_number] => 20030186269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses' [patent_app_type] => new [patent_app_number] => 10/276372 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16398 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186269.pdf [firstpage_image] =>[orig_patent_app_number] => 10276372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730142 [patent_doc_number] => 20030186332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Neurotrophic factor expression-inducing agent' [patent_app_type] => new [patent_app_number] => 10/239487 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5421 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186332.pdf [firstpage_image] =>[orig_patent_app_number] => 10239487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967058 [patent_doc_number] => 20050233955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Stimulation of nerve cell regeneration' [patent_app_type] => utility [patent_app_number] => 10/510065 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12917 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233955.pdf [firstpage_image] =>[orig_patent_app_number] => 10510065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822323 [patent_doc_number] => 20030220484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Modified ciliary neurotrophic factors' [patent_app_type] => new [patent_app_number] => 10/383916 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5169 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220484.pdf [firstpage_image] =>[orig_patent_app_number] => 10383916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6634439 [patent_doc_number] => 20030211549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Functional proteins and therapeutic and diagnostic methods for use thereof' [patent_app_type] => new [patent_app_number] => 10/373617 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8306 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211549.pdf [firstpage_image] =>[orig_patent_app_number] => 10373617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847394 [patent_doc_number] => 20030166561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Peptide' [patent_app_type] => new [patent_app_number] => 10/374624 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13044 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166561.pdf [firstpage_image] =>[orig_patent_app_number] => 10374624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664057 [patent_doc_number] => 20030203383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Novel neurotrophic factor immunoassays' [patent_app_type] => new [patent_app_number] => 10/371003 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14698 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203383.pdf [firstpage_image] =>[orig_patent_app_number] => 10371003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696847 [patent_doc_number] => 20030109041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Lineage restricted glial precursors from the central nervous system' [patent_app_type] => new [patent_app_number] => 10/335354 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11305 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109041.pdf [firstpage_image] =>[orig_patent_app_number] => 10335354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761309 [patent_doc_number] => 20030124671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Truncated hepatocyte growth factor variants' [patent_app_type] => new [patent_app_number] => 10/283769 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17983 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124671.pdf [firstpage_image] =>[orig_patent_app_number] => 10283769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645414 [patent_doc_number] => 07119066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Modified ciliary neurotrophic factor (CNTF)' [patent_app_type] => utility [patent_app_number] => 10/281643 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 21334 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119066.pdf [firstpage_image] =>[orig_patent_app_number] => 10281643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765225 [patent_doc_number] => 20030099623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression' [patent_app_type] => new [patent_app_number] => 10/279568 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14343 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099623.pdf [firstpage_image] =>[orig_patent_app_number] => 10279568 [rel_patent_id] =>[rel_patent_doc_number] =>)